Workshop: Kinase Ligand Design

webinar

Thu, 01 Feb 2024, 16:00 CET (Berlin)

Dr. Alexander Neumann, BioSolveIT

Workshop: Kinase Ligand Design

Kinases stand out as a popular focus in drug development. Their popularity is evident from the numerous FDA approvals granted to compounds targeting these specific proteins. The associated design process often integrates computational approaches such as molecular modeling and structure-based drug design, reflecting the dynamic and evolving landscape of kinase-targeted drug development.

This BioSolveIT workshop is dedicated to elucidating the basics of selective kinase inhibitor design, as well as the application of advanced techniques to optimize lead structures. Encompassing both the 3D structure-based and the 2D ligand-based realms, we will present and discuss several examples illustrating idea generation methods for hinge binders and the adjacent core regions. These methods will include fragment-based growing (FBDD), scaffold hopping, Chemical Space exploration involving trillions of possibilities, and various other strategies facilitated by BioSolveIT tools.

Drug discovery beginners, veterans, and medicinal chemistry enthusiasts are invited to join this highly informative workshop and the subsequent discussion.

Participants can request a certificate of attendance to confirm their completion of the event to furthering their knowledge and skills in the specified subject matter.

Current news

category
Events
UK-QSAR 2026: Registrations Are Open
January 21, 2026 16:45 CET
We’re excited to announce that registrations are now open for the UK-QSAR & Cheminformatics Society Meeting Spring 2026, taking place 21 April 2026 in Edinburgh (UK). This year’s meeting is co-hosted by BioSolveIT and Enamine and brings together cheminformatics and QSAR enthusiasts from academia and industry for a day of...
Read on
category
Events
AI/ML in Early Drug Discovery: From Data to Decisions (Hybrid Colloquium)
January 21, 2026 11:40 CET
We invite biotech/pharma investors, VCs, computational chemists, and medicinal chemists. Join Congruence Therapeutics for a focused industry colloquium exploring practical AI/ML workflows in early small molecule drug discovery. This event brings together experts to discuss how AI/ML is being applied in real discovery programs today, separating real impact from platform...
Read on
Tool of the Month - SpaceLight
January 19, 2026 13:46 CET
Spotlight on SpaceLight: Navigating Billions Efficiently In the search for the next lead candidate, medicinal chemists must balance structural similarity with the requirement for synthetic accessibility. This month, we spotlight SpaceLight, our algorithm designed to navigate the “beyond-billion” scale of Chemical Spaces with high accuracy.   What Does SpaceLight Do?...
Read on